RAPS Convergence 2024: MedEnvoy Key Takeaways
From September 17th to 19th, 2024, the MedEnvoy team attended RAPS Convergence 2024. This event brought together regulatory affairs…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 289–297 of 396
From September 17th to 19th, 2024, the MedEnvoy team attended RAPS Convergence 2024. This event brought together regulatory affairs…
Medical device classification is the first major step in the regulatory process, whether you’re aiming to sell in the United…
Using any type of product in a manner not intended by its manufacturer has the potential to cause harm, a…
As the September 26, 2024, deadline for MDR Conformity Assessment Agreements rapidly approaches, medical device manufacturers are reminded of the…
The FDA has recently issued a draft guidance for Predetermined Change Control Plans (PCCP) for Medical Devices. The draft guidance,…
Classifying your medical device or in vitro diagnostic device (IVD) under the FDA is one of the first steps in…
In a previous article (available here), we provided an overview of Australia’s Prescribed List, the medical device reimbursement process…
Personal protective equipment (PPE) is a daily necessity in many occupations, including healthcare, and it is important to understand their…
Nearly three years have passed since the US FDA, Health Canada, and UK MHRA jointly identified ten guiding principles in…
Showing 289–297 of 396